Aehr Test's stock surged 7.20% during the pre-market trading session, marking a significant recovery move for the semiconductor equipment company.
The sharp rise follows two consecutive sessions of significant declines from the stock's 52-week high. The rebound is attributed to technical recovery demand emerging after the rapid selloff released substantial selling pressure, creating oversold conditions that triggered short-term buying interest.
The broader Semiconductor Equipment sector showed signs of recovery, with peers like Teradyne posting significant gains, which contributed to the positive momentum for Aehr Test. Previously, the stock had experienced volatility after securing a substantial AI chip testing order followed by a stock offering that created dilution concerns.
Comments